Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity

By del Canho R.   Grosheide P.M.   Mazel J.A.   Heijtink R.A.   Hop W.C.J.   Gerards L.J.   de Gast G.C.   Fetter W.P.F.   Zwijneberg J.   Schalm S.W.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1624-1630

Elsevier

Access to resources Recommend Favorite

Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study

By Kurugol Z.   Erensoy S.   Aksit S.   Egemen A.   Bilgic A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3936-3939

Elsevier

Access to resources Recommend Favorite

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

By Liao S.-s.   Li R.-c.   Li H.   Yang J.-y.   Zeng X.-j.   Gong J.   Wang S.-s.   Li Y.-p.   Zhang K.-l.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2661-2666

Elsevier

Access to resources Recommend Favorite

Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination

By Asahi T.   Ueda K.   Hidaka Y.   Miyazaki C.   Tanaka Y.   Nishima S.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1791-1795

Elsevier

Access to resources Recommend Favorite

A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants

By Ping-Ing L.   Chin-Yun L.   Li-Min H.   Jong-Min C.   Mei-Hwei C.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1685-1689

Elsevier

Access to resources Recommend Favorite